Cosmo Pharmaceuticals N.V.
Simbol: COPN.SW
SIX
71.4
CHFPrețul de piață astăzi
1009.1513
Raportul P/E
14.6994
Raportul PEG
1.15B
MRK Cap
- 0.01%
Randament DIV
Cosmo Pharmaceuticals N.V. (COPN-SW) Situații financiare
Bilanț
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 50.3 | 241 | 222.2 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 55.1 | 23.6 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 0 | 28.5 | 38.6 | 24.5 | ||||||||||||||||||||
balance-sheet.row.inventory | 0 | 14.2 | 11.5 | 13.1 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 0 | 9.3 | 53.6 | 39.7 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 0 | 102.2 | 306.1 | 275.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 28.6 | 30.3 | 30.5 | ||||||||||||||||||||
balance-sheet.row.goodwill | 0 | 24 | 24 | 24 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 0 | 355.6 | 366.8 | 372.7 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 379.6 | 390.8 | 396.7 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 0 | 3.3 | -46.9 | 25.4 | ||||||||||||||||||||
balance-sheet.row.tax-assets | 0 | 0 | 14.7 | 18.6 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 40.3 | 64.5 | 58.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 451.8 | 453.5 | 529.7 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 0 | 554 | 759.6 | 805.6 | ||||||||||||||||||||
balance-sheet.row.account-payables | 0 | 8.8 | 10.7 | 11.6 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 0 | 0.1 | 171.8 | 0.9 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 2.7 | 3.6 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 0.9 | 1.8 | 169 | ||||||||||||||||||||
Deferred Revenue Non Current | 0 | 0 | 0 | 0.5 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 0 | 14.3 | 12.5 | 3.2 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 97.2 | 100.9 | 271.6 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 1.3 | 2 | 2.6 | ||||||||||||||||||||
balance-sheet.row.total-liab | 0 | 120.3 | 295.8 | 292.9 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 11.5 | 18.4 | ||||||||||||||||||||
balance-sheet.row.common-stock | 0 | 4.6 | 4.6 | 4.6 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | 0 | 302.6 | 262.2 | 293.3 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -22.7 | -11.5 | -18.4 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | 142.3 | 190.1 | 207.4 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 426.8 | 456.9 | 505.3 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 554 | 759.6 | 805.6 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 6.9 | 6.9 | 7.4 | ||||||||||||||||||||
balance-sheet.row.total-equity | 0 | 433.6 | 463.8 | 512.7 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||||||||||
Total Investments | 0 | 3.3 | 8.3 | 49.1 | ||||||||||||||||||||
balance-sheet.row.total-debt | 0 | 1.1 | 173.6 | 169.9 | ||||||||||||||||||||
balance-sheet.row.net-debt | 0 | -49.2 | -12.2 | -28.6 |
Situația fluxurilor de numerar
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 24.5 | 24 | -6.9 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 13.9 | 7.4 | 6 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | -21.4 | 5.9 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 2.1 | 1.5 | 9 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | 0 | -13.3 | -5.1 | -5.1 | |||||||||||||||||||
cash-flows.row.account-receivables | 0 | -14.2 | 3.3 | -7.9 | |||||||||||||||||||
cash-flows.row.inventory | 0 | 1.6 | -6.1 | 0.4 | |||||||||||||||||||
cash-flows.row.account-payables | 0 | 14.2 | -3.3 | 7.9 | |||||||||||||||||||
cash-flows.row.other-working-capital | 0 | -14.9 | 1 | -5.6 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 0 | 6.1 | 6.2 | 4.2 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7.3 | -8.5 | -8.1 | |||||||||||||||||||
cash-flows.row.acquisitions-net | 0 | 0 | 23.3 | -4.1 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | 0 | -54 | -1 | -20 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 35.9 | 7.7 | 131.6 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 0 | 27.1 | 3.3 | -23.9 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | 1.7 | 24.9 | 75.4 | |||||||||||||||||||
cash-flows.row.debt-repayment | 0 | -0.9 | -2.6 | -1.8 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0.3 | 0.8 | 5.3 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | -24.7 | -19.7 | -11 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -15.6 | -0.8 | 0 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 0 | -5.1 | -4.9 | -4.4 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -46.1 | -27.2 | -11.9 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -1.5 | 2.4 | -1 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 0 | -12.7 | 12.6 | 75.5 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 185.8 | 198.6 | 185.9 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 198.6 | 185.9 | 110.4 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | 0 | 33.2 | 12.6 | 13 | |||||||||||||||||||
cash-flows.row.capital-expenditure | 0 | -7.3 | -8.5 | -8.1 | |||||||||||||||||||
cash-flows.row.free-cash-flow | 0 | 25.9 | 4.1 | 4.9 |
Rândul din contul de profit și pierdere
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 96.7 | 102.1 | 65.1 | ||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 39.3 | 18.8 | 15.1 | ||||||||||||||||||||
income-statement-row.row.gross-profit | 0 | 57.4 | 83.3 | 49.9 | ||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 51.7 | 36 | ||||||||||||||||||||
income-statement-row.row.operating-expenses | 0 | 45.3 | 55.3 | 38.8 | ||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 84.7 | 74 | 54 | ||||||||||||||||||||
income-statement-row.row.interest-income | 0 | 4.5 | 2.9 | 3.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 9.2 | 9 | ||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -4.6 | -3.6 | -9.1 | ||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 51.7 | 36 | ||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -4.6 | -3.6 | -9.1 | ||||||||||||||||||||
income-statement-row.row.interest-expense | 0 | 0 | 9.2 | 9 | ||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 13.6 | 19.4 | 7.4 | ||||||||||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||||||||||
income-statement-row.row.operating-income | 0 | 12.2 | 28.1 | 33.1 | ||||||||||||||||||||
income-statement-row.row.income-before-tax | 0 | 7.6 | 24.5 | 24 | ||||||||||||||||||||
income-statement-row.row.income-tax-expense | 0 | 6.3 | 7 | 2.3 | ||||||||||||||||||||
income-statement-row.row.net-income | 0 | 1.1 | 17.2 | 21.7 |
Întrebări frecvente
Ce este Cosmo Pharmaceuticals N.V. (COPN.SW) totalul activelor?
Cosmo Pharmaceuticals N.V. (COPN.SW) activele totale sunt 553980000.000.
Care este venitul anual al întreprinderii?
Venitul anual este N/A.
Care este marja de profit a întreprinderii?
Marja de profit a firmei este 0.593.
Care este fluxul de numerar liber al întreprinderii?
Fluxul de numerar liber este 1.901.
Care este marja de profit net a întreprinderii?
Marja profitului net este 0.012.
Care este venitul total al întreprinderii?
Venitul total este 0.126.
Care este Cosmo Pharmaceuticals N.V. (COPN.SW) profitul net (venitul net)?
Profitul net (venitul net) este 1147000.000.
Care este datoria totală a firmei?
Datoria totală este 1079000.000.
Care este numărul cheltuielilor de exploatare?
Cheltuielile de exploatare sunt 45314000.000.
Care este cifra de numerar a firmei?
Numerarul întreprinderii este 0.000.